DAVID GRAHAM to Gastroesophageal Reflux
This is a "connection" page, showing publications DAVID GRAHAM has written about Gastroesophageal Reflux.
Connection Strength
3.117
-
Optimal PPI Dosing for Improving GERD Symptoms: Is Timing Everything? Dig Dis Sci. 2019 01; 64(1):4-6.
Score: 0.469
-
Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency. Clin Gastroenterol Hepatol. 2018 06; 16(6):800-808.e7.
Score: 0.430
-
Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia. Scand J Gastroenterol. 2016 Nov; 51(11):1281-7.
Score: 0.395
-
The acid pocket: rediscovery of an old concept. Am J Gastroenterol. 2014 Jan; 109(1):136-7.
Score: 0.332
-
Failures in a proton pump inhibitor therapeutic substitution program: lessons learned. Dig Dis Sci. 2007 Oct; 52(10):2813-20.
Score: 0.208
-
Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Minerva Gastroenterol Dietol. 2006 Sep; 52(3):235-48.
Score: 0.200
-
The changing epidemiology of GERD: geography and Helicobacter pylori. Am J Gastroenterol. 2003 Jul; 98(7):1462-70.
Score: 0.160
-
Helicobacter pylori is not and never was "protective" against anything, including GERD. Dig Dis Sci. 2003 Apr; 48(4):629-30.
Score: 0.157
-
Management of upper gastrointestinal symptoms in patients with autoimmune gastritis. Curr Opin Gastroenterol. 2022 11 01; 38(6):600-606.
Score: 0.151
-
Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014 Dec; 109(12):1870-80.
Score: 0.088
-
Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology. 1989 Mar; 96(3):683-9.
Score: 0.059
-
Multidimensional measure for gastroesophageal reflux disease (MM-GERD) symptoms in children: a population-based study. Acta Paediatr. 2008 Sep; 97(9):1292-7.
Score: 0.056
-
Diet, lifestyle and gender in gastro-esophageal reflux disease. Dig Dis Sci. 2008 Aug; 53(8):2027-32.
Score: 0.054
-
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005 Jun; 100(6):1243-50.
Score: 0.046
-
Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004 Jun; 126(7):1692-9.
Score: 0.043
-
Changing patterns of peptic ulcer, gastro-oesophageal reflux disease and Helicobacter pylori: a unifying hypothesis. Eur J Gastroenterol Hepatol. 2003 May; 15(5):571-2.
Score: 0.040
-
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020 12; 69(12):2093-2112.
Score: 0.033
-
Helicobacter pylori. Med Clin North Am. 2000 Sep; 84(5):1125-36, viii.
Score: 0.033
-
Comparison of agar gel (CLOtest) or reagent strip (PyloriTek) rapid urease tests for detection of Helicobacter pylori infection. Am J Gastroenterol. 1997 Jun; 92(6):997-9.
Score: 0.026
-
Histological features do not define NSAID-induced gastritis. Hum Pathol. 1996 Dec; 27(12):1348-54.
Score: 0.025
-
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol. 2013 Oct; 108(10):1576-83.
Score: 0.020
-
Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut. 2014 Feb; 63(2):220-9.
Score: 0.020
-
Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J Clin Gastroenterol. 2012 May-Jun; 46(5):397-400.
Score: 0.018
-
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012 May; 61(5):646-64.
Score: 0.018
-
Prevalence and determinants of histological abnormalities of the gastric cardia in volunteers. Scand J Gastroenterol. 2007 Oct; 42(10):1158-66.
Score: 0.013
-
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007 Jun; 56(6):772-81.
Score: 0.013
-
Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000. Curr Pharm Des. 2000 Oct; 6(15):1503-14.
Score: 0.008